Cargando…
Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2
BACKGROUND: Rigors are a significant adverse event during interleukin-2 (IL2) therapy for metastatic melanoma and renal cell carcinoma. Meperidine has been a mainstay for rigor prophylaxis but there is a paucity of data regarding possible alternatives. METHODS: Ninety one patients receiving IL2 ther...
Autores principales: | Khong, Brian, Lawson, Benjamin O., Ma, Junjie, McGovern, Cheryl, Van Atta, Joan K., Ray, Abhijit, Khong, Hung T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195987/ https://www.ncbi.nlm.nih.gov/pubmed/30342473 http://dx.doi.org/10.1186/s12885-018-4810-y |
Ejemplares similares
-
Neutrophil-to-lymphocyte Ratio (NLR) as a predictor for recurrence in patients with stage III melanoma
por: Ma, Junjie, et al.
Publicado: (2018) -
Mitf-Mdel, a novel melanocyte/melanoma-specific isoform of microphthalmia-associated transcription factor-M, as a candidate biomarker for melanoma
por: Wang, Yixiang, et al.
Publicado: (2010) -
IL-21 Modulates Activation of NKT Cells in Patients with Stage IV Malignant Melanoma
por: Coquet, Jonathan M, et al.
Publicado: (2013) -
The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
por: Khong, Ka-Wa, et al.
Publicado: (2022) -
Getting rigorous with scientific rigor
por: Hofseth, Lorne J
Publicado: (2018)